Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Study of JNS020QD (Fentanyl Patch) in Chronic Pain
NCT00788372Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Nov 2008
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fentanyl (transdermal patch + oral transmucosal lozenge) in chronic pain, sponsored by Janssen Pharmaceutical. Started Nov 2008; status: completed.
02
Drugs
fentanyl (transdermal patch + oral transmucosal lozenge)
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT00788372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00788372.